ELAVL1 overexpression potentiates cervical cancer malignancy via regulating the ACVRL1/CASP14 pathway

Abstract

Cervical cancer is the fourth common gynecological malignancy. To explore new therapeutic targets, we found that the transcriptional and translational levels of ELAVL1 were markedly increased in SiHa and HeLa cells as well as cervical cancer specimens. Knockdown of ELAVL1 substantially suppressed the proliferation, invasion, and migration of cervical cancer cells, while inducing apoptosis. Conversely, overexpression of ELAVL1 resulted in a substantial increase in the proliferative, invasive, and migratory capacities of SiHa cells. Bioinformatics predictions, RIP-qPCR and dual-luciferase reporter assays indicated that ELAVL1 might interact with the 3′UTR of ACVRL1, and upregulate ACVRL1 and CASP14 expression. Co-transfection experiments and functional assays revealed that ELAVL1 might modulate malignant phenotypes of cervical cancer cells via the ACVRL1/CASP14 pathway. Furthermore, in vivo si-ELAVL1 administration significantly inhibited tumor growth in nude mouse xenograft models. ELAVL1 may promote cervical cancer progression, potentially through regulating the ACVRL1/CASP14 pathway, rendering ELAVL1 a potential candidate for therapeutic intervention.

Protection of beta-blocker and 5-hydroxytryptamine 1A receptor agonist on myocardial ischemia injury in rats by regulating the NLRP3/Caspase-1/GSDMD pathway
Haiyang Chen, Yanwei Li, Meiyan Liu +2
PLOS One14 Oct 2026Peer-reviewedCC BY 4.0Full textImmunologyPLOS
Yixintai granules enhance glucose and lipid metabolism after ischemic heart failure by regulating inflammatory factors via the LPS/TLR4/NF-κB signaling pathway
Ziyan Wang, Chengxin Liu, Jiaming Wei +10
Frontiers in Immunology16 Oct 2026Peer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMCPMC
Single-Gene Overexpression of Pigeon Pea (Cajanus cajan) CcSBPase or CcSHMT1 and Multigene Overexpression of CcSBPase with CcSTN7 Do Not Impact Physiological Responses to Water Deficit Stress in Tobacco (Nicotiana tabacum)
Malizukiswe Vincent Vacu, Bianke Loedolff, Shaun Peters
Plants (Basel, Switzerland)29 Sep 2026Peer-reviewedCC BYFull textPlant biologyEurope PMC
High Light Intensity Potentiates Bacillus amyloliquefaciens PMB05-Associated Plant Immunity and Bacterial Soft Rot Control in Arabidopsis thaliana
Ai-Ting Li, Yun-Chen Tsai, Yun-Ching Tsai +4
Plants (Basel, Switzerland)22 Sep 2026Peer-reviewedCC BYFull textPlant biologyEurope PMC
Endothelin receptor blockade potentiates adoptive T cell and CAR T cell therapies
C. Papagregoiou, F. Mpekris, J. Yoon +14
bioRxiv2 Sep 2026PreprintAll rights reservedFull textImmunologybioRxiv

Cite

BibTeX RIS

BibTeX

@article{liu2026elavl1,
  title = {{ELAVL1 overexpression potentiates cervical cancer malignancy via regulating the ACVRL1/CASP14 pathway}},
  author = {Jianbing Liu and Jinjuan Wang and Ying Gao and Xiaohua Cui and Wei Wang and Haixia Ma and Yongzhi Jiao and Jing Xu and Jianqing Hao and Zhifang Xu and Li Li and Min Hao},
  journal = {iScience},
  year = {2026},
  month = oct,
  doi = {10.1016/j.isci.2026.117956},
  url = {https://www.cell.com/iscience/fulltext/S2589-0042(26)03339-0},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - ELAVL1 overexpression potentiates cervical cancer malignancy via regulating the ACVRL1/CASP14 pathway
AU  - Jianbing Liu
AU  - Jinjuan Wang
AU  - Ying Gao
AU  - Xiaohua Cui
AU  - Wei Wang
AU  - Haixia Ma
AU  - Yongzhi Jiao
AU  - Jing Xu
AU  - Jianqing Hao
AU  - Zhifang Xu
AU  - Li Li
AU  - Min Hao
PY  - 2026
DA  - 2026/10/20
JO  - iScience
DO  - 10.1016/j.isci.2026.117956
UR  - https://www.cell.com/iscience/fulltext/S2589-0042(26)03339-0
AB  - Cervical cancer is the fourth common gynecological malignancy. To explore new therapeutic targets, we found that the transcriptional and translational levels of ELAVL1 were markedly increased in SiHa and HeLa cells as well as cervical cancer specimens. Knockdown of ELAVL1 substantially suppressed the proliferation, invasion, and migration of cervical cancer cells, while inducing apoptosis. Conversely, overexpression of ELAVL1 resulted in a substantial increase in the proliferative, invasive, and migratory capacities of SiHa cells. Bioinformatics predictions, RIP-qPCR and dual-luciferase reporter assays indicated that ELAVL1 might interact with the 3′UTR of ACVRL1, and upregulate ACVRL1 and CASP14 expression. Co-transfection experiments and functional assays revealed that ELAVL1 might modulate malignant phenotypes of cervical cancer cells via the ACVRL1/CASP14 pathway. Furthermore, in vivo si-ELAVL1 administration significantly inhibited tumor growth in nude mouse xenograft models. ELAVL1 may promote cervical cancer progression, potentially through regulating the ACVRL1/CASP14 pathway, rendering ELAVL1 a potential candidate for therapeutic intervention.
SN  - 2589-0042
ER  -

Abstract

Related

Cite